Sodium Iodide Market

Sodium Iodide Market Size, Share & Industry Analysis, By Source:- Synthetic, Recombinant DNA technology, By End-User:- Hospitals, Retail Pharmacies, Online Pharmacies, and Forecast Period 2025-2035

The Sodium Iodide market is projected to grow at a CAGR of 5.7% from 2025 to 2035, driven by increasing demand in nuclear medicine, expanding use in diagnostic imaging, and growing applications in nutritional supplementation and pharmaceuticals. Sodium Iodide (NaI) is an inorganic salt composed of sodium and iodine, known for its solubility, bioavailability, and radiolabeling capabilities. It is especially valued for its role in medical imaging and therapy due to its ability to carry radioactive isotopes.

In healthcare, radioactive Sodium Iodide (I-131) is extensively used in the diagnosis and treatment of thyroid disorders, including hyperthyroidism and thyroid cancer. Non-radioactive forms are used as dietary supplements to address iodine deficiency and in pharmaceutical formulations. Additionally, Sodium Iodide is applied in scintillation detectors for radiation detection and in the chemical industry for organic synthesis and catalysis.

North America leads the Sodium Iodide market due to strong nuclear medicine infrastructure, widespread diagnostic imaging usage, and high prevalence of thyroid conditions. Europe follows with consistent demand driven by iodine deficiency prevention programs and nuclear diagnostics. The Asia-Pacific region is expected to experience the fastest growth, supported by expanding healthcare access, increasing awareness of iodine nutrition, and growing investment in nuclear medicine technologies in countries such as China, India, and Japan. Latin America and the Middle East & Africa show gradual growth with rising healthcare infrastructure and nutritional health initiatives.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Sodium Iodide
  • Key End-Users & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
  • Synthetic
  • Recombinant DNA technology
  • Key End-Use Industries
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Trade Analysis
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, and Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Production Capacity
  • Company Profiles & Key Developments
  • Calibre Chemicals
  • Vishal Laboratories
  • DNS Fine Chemicals and Laboratories Pvt. Ltd.
  • Anmol Chemicals
  • Omkar Speciality Chemicals Ltd.
  • Infinium Pharmachem Pvt. Ltd.
  • Deepwater Chemicals
  • Parchem – Fine & Specialty Chemicals
  • Avantor (VWR)
  • Lab Alley
  • Ajay North America, LLC
  • Junsei Chemical Co., Ltd.
  • Kishida Chemical Co., Ltd.
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Sodium Iodide?
Sodium Iodide is a white, crystalline salt composed of sodium and iodine, commonly used in medical imaging, pharmaceuticals, animal nutrition, and chemical synthesis. In medicine, it is widely utilized as a radioactive tracer (I-131) for thyroid diagnostics and therapy, and in non-radioactive form, it is used as an iodine supplement in both human and animal health to prevent iodine deficiency.
What is the market growth of Sodium Iodide?
The global Sodium Iodide market is projected to grow at a CAGR of 5.7% from 2025 to 2035, increasing from approximately USD 360 million in 2025 to around USD 590 million by 2035. This growth is driven by the expanding use of nuclear medicine, thyroid disorder treatments, and the increasing demand for iodine supplementation in public health and agriculture.
What are the drivers of the Sodium Iodide market?
Key drivers include the rising prevalence of thyroid-related diseases, especially hyperthyroidism and thyroid cancer, growing use of radioactive iodine (I-131) in nuclear imaging and radiotherapy, and the global emphasis on iodine deficiency prevention through dietary supplementation. Demand from veterinary medicine, laboratory reagents, and radiopharmaceuticals also supports market expansion.
Who are the key players operating in the Sodium Iodide market?
Leading players include GE Healthcare, Mallinckrodt Pharmaceuticals, Nordion Inc., Thermo Fisher Scientific, Merck KGaA, and Iofina plc. These companies produce both radioactive and non-radioactive forms of Sodium Iodide, supplying healthcare institutions, laboratories, and animal nutrition sectors.
Which region will exhibit the fastest growth in the Sodium Iodide market?
The North American region is expected to maintain a leading position due to the widespread use of nuclear medicine, strong healthcare infrastructure, and high thyroid disorder prevalence. The Asia-Pacific region is projected to experience the fastest growth due to increasing thyroid disease screening, expanding access to diagnostic imaging, and government efforts to address iodine deficiency in countries like India and China.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.